It is currently unclear what causes the chronic inflammation within atherosclerotic plaques.
One emerging paradigm suggests that infection with bacteria and/or viruses can contribute …

Aims With the success of antiretroviral therapy (ART), non-human immunodeficiency virus
(HIV)-related comorbidities like cardiovascular diseases (CVDs) are of increasing concern …

Patients with human immunodeficiency virus (HIV) infection are at increased risk of
developing coronary heart disease (CHD). Although factors potentially contributing to this …

Background There is increased risk of cardiovascular disease among HIV seropositive
individuals. The prevalence of HIV is highest in sub-Saharan Africa; however, HIV-related …

As antiretroviral therapy has decreased human immunodeficiency virus (HIV)–associated
mortality, cardiometabolic abnormalities have become increasingly apparent in HIV-infected …

Objective To investigate whether there is an increased risk of cardiovascular events in
people who exhibit iatrogenic Cushing's syndrome during treatment with glucocorticoids …

Although even recently human immunodeficiency virus (HIV)–infected patients have mainly
encountered AIDS-defining morbid events and early AIDS-related mortality, at present, in …

Background This study investigates the association of clinical and demographic predictors
with abdominal fat gain, measured using waist circumference (WC) and self-reported …

Background: The introduction and widespread use of combination antiretroviral therapy
referred to as highly active antiretroviral therapy (HAART) in the mid 1990's, has led HIV …

Context: Little is known about renin-angiotensin-aldosterone system (RAAS) activation in
relationship to visceral adipose tissue (VAT) accumulation in HIV-infected patients, a …